Discussing the Next Generation of Predictive Biomarkers and Targeted Therapies in Gastrointestinal Malignancies

Discussing the Next Generation of Predictive Biomarkers and Targeted Therapies in Gastrointestinal Malignancies is organized by Clinical Care Options (CCO), LLC.,Released: March 29, 2023,Expiration: March 28, 2024,Program Learning Goal:,The goal of this program is to improve the knowledge and competence of learners in the assessment of predictive biomarkers to guide the individualized treatment of patients with gastrointestinal malignancies.,Learning Objectives:,Upon completion of this activity, participants should be able to:,• Implement evidence-based molecular testing in GI cancers, including BRAF V600E, HER2/HER3, BRCA1/2, FGFR2, IDH1, and histology-agnostic markers,• Plan targeted therapeutic strategies for patients with GI malignancies based on predictive biomarker assessment, available data, and expert recommendations,• Counsel patients about their tumor molecular profile and how this information will guide therapy decisions,• Identify patients with GI malignancies eligible for enrollment in ongoing clinical trials of novel biomarker-driven treatment strategies